This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Figure 1
Percentage of weak biofilm forming (WBF, 2 total), intermediate biofilm forming (IBF, 11 total), strong biofilm forming (SBF, 2 total) and all P. mirabilis strains (ALL) in various clinical materials.
Figure 2
Percentage of weak biofilm forming (WBF), intermediate biofilm forming (IBF), strong biofilm forming (SBF), and all P. mirabilis strains in different service units.(PE = pediatric emergency (5 total), EMD = endocrine and metabolic diseases (1 total), URO = urology (2 total), EM = emergency medicine (2 total), O = otorhinolaryngology (1 total), GS = general surgery (1 total), PED = pediatrics (3 total)
Figure 3
Percentage of weak biofilm forming (WBF), intermediate biofilm forming (IBF), strong biofilm forming (SBF) and all P. mirabilis strains (ALL) in individuals of various ages. (16-30 y, 4 strains total; 46-60 y and 61-75 y 1 strain each)
Figure 4
Percentage of weak biofilm forming (WBF), intermediate biofilm forming (IBF), strong biofilm forming (SBF) and all P. mirabilis strains (ALL) displaying resistance to 15 different antibiotics in various classes of antibiotics (SXT = trimethoprim/sulfamethoxazole, AMC = amoxicillin/clavulanic acid, CFM = cefixime, CIP = ciprofloxacin, CC = clindamycin, AK = amikacin, CN = gentamicin, CAZ = cefazolin, NN = tobramycin, AM = ampicillin, CRO = ceftriaxone, CZ = ceftazidime, TZP = piperacillin/tazobactam, IPM = imipenem, F = nitrofurantoin)
0.1 ≤ OD < 0.4
Weak Biofilm Former (WBF)
0.4 ≤ OD < 0.8
Intermediate Biofilm Former (IBF)
OD ≥ 0.8
Strong Biofilm Former (SBF)
Percentage of P. mirabilis strains displaying resistance to 5 different classes of antibiotics and percentage of multidrug resistant P. mirabilis strains in each biofilm group.